On March 13, Gucci announced that Demna will be the brand's newest creative director. The 43-year-old designer was formerly ...

Kering lost around $3 billion in stockmarket value on Friday after the group chose in-house talent Demna to reinvigorate its ...

DelveInsight's "ROZLYTREK Market Size, Forecast, and Market Insight Report" highlights the details around ROZLYTREK, an ...

Advanced oncology pipeline including more than 20 active Phase 2 and Phase 3 clinical trials with a strategic focus on two priority pan-tumor ...

NEW YORK — It took five years for Crystal Burke to put a ... When Shevonya Noble joined biotechnology firm Genentech as a ...

DelveInsight's "XPOVIO Market Size, Forecast, and Market Insight Report" highlights the details around XPOVIO, a ...

Sharing his vision, Arvind Bali, Vice Chairman, GTS Techlabs, added, "Through this, we are all set to achieve new benchmarks in enterprise communication within the evolving digital landscape." "At ...

Genentech, a member of the Roche Group, today announced that the U.S. Food and Drug Administration (FDA) has approved TNKase® (tenecteplase), a thrombolytic or clot-dissolving agent, for the treatment ...

Just nine weeks after UnitedHealthcare CEO Brian Thompson was murdered on a weekday morning on a busy street, the luminaries ...

(RTTNews) - Genentech, a member of the Roche Group (RHHBY), announced new positive data from Stage 2 and Stage 3 of the National Institutes of Health (NIH)-sponsored Phase III OUtMATCH study ...

Genentech, a member of the Roche Group, announced new positive data from Stage 2 and Stage 3 of the National Institutes of Health-sponsored Phase III OUtMATCH study, which provide ...